Advertisement

Ads Placeholder
Loading...

NanoRepro AG

NNGRFPNK
Healthcare
Medical - Diagnostics & Research
$12.76
$0.00(0.00%)
U.S. Market opens in 58h 1m

NanoRepro AG Fundamental Analysis

NanoRepro AG (NNGRF) shows weak financial fundamentals with a PE ratio of -68.29, profit margin of -44.02%, and ROE of -5.21%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.79
Current Ratio49.94

Areas of Concern

ROE-5.21%
Operating Margin-77.97%
We analyze NNGRF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -8.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-8.9/100

We analyze NNGRF's fundamental strength across five key dimensions:

Efficiency Score

Weak

NNGRF struggles to generate sufficient returns from assets.

ROA > 10%
-5.24%

Valuation Score

Excellent

NNGRF trades at attractive valuation levels.

PE < 25
-68.29
PEG Ratio < 2
-0.79

Growth Score

Moderate

NNGRF shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

NNGRF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
49.94

Profitability Score

Weak

NNGRF struggles to sustain strong margins.

ROE > 15%
-521.10%
Net Margin ≥ 15%
-44.02%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is NNGRF Expensive or Cheap?

P/E Ratio

NNGRF trades at -68.29 times earnings. This suggests potential undervaluation.

-68.29

PEG Ratio

When adjusting for growth, NNGRF's PEG of -0.79 indicates potential undervaluation.

-0.79

Price to Book

The market values NanoRepro AG at 3.66 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.66

EV/EBITDA

Enterprise value stands at -44.37 times EBITDA. This is generally considered low.

-44.37

How Well Does NNGRF Make Money?

Net Profit Margin

For every $100 in sales, NanoRepro AG keeps $-44.02 as profit after all expenses.

-44.02%

Operating Margin

Core operations generate -77.97 in profit for every $100 in revenue, before interest and taxes.

-77.97%

ROE

Management delivers $-5.21 in profit for every $100 of shareholder equity.

-5.21%

ROA

NanoRepro AG generates $-5.24 in profit for every $100 in assets, demonstrating efficient asset deployment.

-5.24%

Following the Money - Real Cash Generation

Operating Cash Flow

NanoRepro AG generates strong operating cash flow of $10.07M, reflecting robust business health.

$10.07M

Free Cash Flow

NanoRepro AG generates strong free cash flow of $9.66M, providing ample flexibility for dividends, buybacks, or growth.

$9.66M

FCF Per Share

Each share generates $0.75 in free cash annually.

$0.75

FCF Yield

NNGRF converts 6.63% of its market value into free cash.

6.63%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-68.29

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.79

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.66

vs 25 benchmark

P/S Ratio

Price to sales ratio

30.69

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

49.94

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.05

vs 25 benchmark

ROA

Return on assets percentage

-0.05

vs 25 benchmark

ROCE

Return on capital employed

-0.09

vs 25 benchmark

How NNGRF Stacks Against Its Sector Peers

MetricNNGRF ValueSector AveragePerformance
P/E Ratio-68.2928.45 Better (Cheaper)
ROE-5.21%763.00% Weak
Net Margin-44.02%-45265.00% (disorted) Weak
Debt/Equity0.000.34 Strong (Low Leverage)
Current Ratio49.942795.60 Strong Liquidity
ROA-5.24%-16588.00% (disorted) Weak

NNGRF outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews NanoRepro AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ